IG Confirms Many Recovery Act Criminal Investigations
Client Alert | less than 1 min read | 11.03.11
In what should serve as a warning that use of Recovery Act funds continues to draw close scrutiny from federal watchdogs, in written testimony on November 2 before a House subcommittee, DoE Inspector General Friedman revealed that his office has initiated over 100 criminal investigations involving “various schemes, including the submission of false information [and] claims for unallowable or unauthorized expenses,” under the Recovery Act. He also confirmed that his office has “ongoing and planned reviews” of Recovery Act funding and usage.
Contacts
Insights
Client Alert | 7 min read | 06.26.26
Federal Roundup: Updates for PBMs and Medicare Advantage Organizations
In June 2026, federal regulators and lawmakers continued their efforts to improve drug affordability through targeted reforms. These recent developments will primarily impact pharmaceutical manufacturers, managed care organizations, and pharmacy benefit managers (PBM) serving Medicare Part D program members. PBMs, Medicare Advantage organizations, and Part D sponsors should monitor these changes in the interest of maintaining compliance and providing input on regulatory proposals that may influence their business operations or compensation structures in the future.
Client Alert | 6 min read | 06.26.26
Client Alert | 4 min read | 06.25.26
Twin Executive Orders Seek to Spur Quantum Leap in Technology and Cybersecurity
Client Alert | 7 min read | 06.24.26
